Concepts (215)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genome-Wide Association Study | 21 | 2022 | 333 | 1.780 |
Why?
|
| Polymorphism, Single Nucleotide | 21 | 2022 | 767 | 1.090 |
Why?
|
| Quantitative Trait Loci | 4 | 2022 | 77 | 1.080 |
Why?
|
| Obesity | 13 | 2021 | 1067 | 0.710 |
Why?
|
| Models, Statistical | 1 | 2021 | 180 | 0.700 |
Why?
|
| Genetic Loci | 7 | 2018 | 90 | 0.680 |
Why?
|
| Heart Diseases | 2 | 2018 | 104 | 0.660 |
Why?
|
| Body Mass Index | 13 | 2018 | 854 | 0.650 |
Why?
|
| Apolipoproteins E | 1 | 2018 | 129 | 0.590 |
Why?
|
| Heart Rate | 1 | 2018 | 253 | 0.570 |
Why?
|
| Genetic Predisposition to Disease | 13 | 2018 | 628 | 0.530 |
Why?
|
| Blood Glucose | 6 | 2019 | 353 | 0.530 |
Why?
|
| Blood Pressure | 2 | 2023 | 646 | 0.520 |
Why?
|
| Cognition | 2 | 2018 | 398 | 0.520 |
Why?
|
| Alzheimer Disease | 2 | 2023 | 905 | 0.510 |
Why?
|
| Hippocampus | 1 | 2018 | 561 | 0.490 |
Why?
|
| Genotype | 9 | 2018 | 730 | 0.400 |
Why?
|
| Insulin | 4 | 2015 | 236 | 0.380 |
Why?
|
| Humans | 42 | 2023 | 37093 | 0.370 |
Why?
|
| Survival Analysis | 3 | 2021 | 325 | 0.350 |
Why?
|
| Exercise | 4 | 2022 | 613 | 0.350 |
Why?
|
| Dietary Proteins | 3 | 2014 | 32 | 0.340 |
Why?
|
| Phenotype | 7 | 2022 | 689 | 0.340 |
Why?
|
| Body Composition | 2 | 2019 | 162 | 0.320 |
Why?
|
| Aged | 17 | 2022 | 6741 | 0.310 |
Why?
|
| Male | 26 | 2021 | 20025 | 0.300 |
Why?
|
| Cardiovascular Diseases | 4 | 2023 | 664 | 0.290 |
Why?
|
| Female | 26 | 2021 | 20969 | 0.290 |
Why?
|
| Longitudinal Studies | 2 | 2021 | 885 | 0.270 |
Why?
|
| Dietary Fats | 4 | 2014 | 119 | 0.260 |
Why?
|
| Heart Failure | 3 | 2018 | 235 | 0.260 |
Why?
|
| Middle Aged | 20 | 2022 | 10129 | 0.260 |
Why?
|
| Dietary Carbohydrates | 3 | 2014 | 31 | 0.250 |
Why?
|
| Transportation of Patients | 1 | 2022 | 14 | 0.210 |
Why?
|
| Brain-Derived Neurotrophic Factor | 3 | 2019 | 61 | 0.210 |
Why?
|
| Risk Factors | 8 | 2019 | 3562 | 0.210 |
Why?
|
| Triglycerides | 3 | 2019 | 138 | 0.210 |
Why?
|
| Energy Intake | 4 | 2018 | 170 | 0.200 |
Why?
|
| Insulin Resistance | 2 | 2015 | 184 | 0.200 |
Why?
|
| Patient Participation | 1 | 2022 | 75 | 0.200 |
Why?
|
| Body Height | 2 | 2013 | 53 | 0.200 |
Why?
|
| Receptors, Cell Surface | 1 | 2022 | 144 | 0.200 |
Why?
|
| Bariatric Surgery | 1 | 2021 | 17 | 0.190 |
Why?
|
| Clinical Trials as Topic | 1 | 2022 | 204 | 0.190 |
Why?
|
| Gastric Bypass | 1 | 2021 | 17 | 0.190 |
Why?
|
| Aged, 80 and over | 5 | 2018 | 2379 | 0.190 |
Why?
|
| Proportional Hazards Models | 3 | 2018 | 441 | 0.190 |
Why?
|
| Bayes Theorem | 1 | 2021 | 94 | 0.190 |
Why?
|
| Weight Loss | 1 | 2021 | 131 | 0.180 |
Why?
|
| Intensive Care Units | 2 | 2017 | 59 | 0.180 |
Why?
|
| Fibroblast Growth Factors | 3 | 2018 | 33 | 0.180 |
Why?
|
| Overweight | 2 | 2019 | 247 | 0.180 |
Why?
|
| Lipoproteins, LDL | 1 | 2019 | 62 | 0.170 |
Why?
|
| Cohort Studies | 7 | 2018 | 1492 | 0.170 |
Why?
|
| Epistasis, Genetic | 2 | 2017 | 16 | 0.170 |
Why?
|
| Anorexia Nervosa | 1 | 2018 | 6 | 0.170 |
Why?
|
| Adiposity | 2 | 2017 | 154 | 0.160 |
Why?
|
| Computer Simulation | 1 | 2021 | 362 | 0.160 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2019 | 289 | 0.160 |
Why?
|
| Vital Capacity | 1 | 2018 | 39 | 0.160 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2019 | 481 | 0.160 |
Why?
|
| Forced Expiratory Volume | 1 | 2018 | 70 | 0.160 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2017 | 14 | 0.160 |
Why?
|
| Docosahexaenoic Acids | 1 | 2017 | 18 | 0.160 |
Why?
|
| Antihypertensive Agents | 1 | 2021 | 284 | 0.150 |
Why?
|
| Seafood | 1 | 2017 | 23 | 0.150 |
Why?
|
| Neuropsychological Tests | 1 | 2018 | 259 | 0.150 |
Why?
|
| Critical Illness | 1 | 2017 | 38 | 0.150 |
Why?
|
| Alleles | 5 | 2016 | 321 | 0.140 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2014 | 77 | 0.140 |
Why?
|
| Patient Selection | 1 | 2017 | 164 | 0.140 |
Why?
|
| Receptors, Cytokine | 1 | 2016 | 12 | 0.140 |
Why?
|
| Apolipoprotein E4 | 1 | 2016 | 47 | 0.140 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2018 | 149 | 0.140 |
Why?
|
| Expiratory Reserve Volume | 1 | 2015 | 2 | 0.130 |
Why?
|
| Functional Residual Capacity | 1 | 2015 | 2 | 0.130 |
Why?
|
| Mental Disorders | 1 | 2019 | 309 | 0.130 |
Why?
|
| Meat Products | 1 | 2015 | 5 | 0.130 |
Why?
|
| Hyperinsulinism | 1 | 2015 | 17 | 0.130 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2016 | 80 | 0.130 |
Why?
|
| Meat | 1 | 2015 | 43 | 0.130 |
Why?
|
| Insulin-Secreting Cells | 1 | 2015 | 28 | 0.130 |
Why?
|
| Sepsis | 1 | 2016 | 80 | 0.130 |
Why?
|
| Adult | 11 | 2021 | 11712 | 0.130 |
Why?
|
| Coffea | 1 | 2014 | 3 | 0.130 |
Why?
|
| Atrial Fibrillation | 1 | 2016 | 101 | 0.120 |
Why?
|
| Hyperglycemia | 1 | 2015 | 55 | 0.120 |
Why?
|
| Cholesterol, LDL | 1 | 2014 | 68 | 0.120 |
Why?
|
| Fasting | 2 | 2012 | 54 | 0.120 |
Why?
|
| Chromosome Mapping | 2 | 2012 | 188 | 0.120 |
Why?
|
| Hypertension | 1 | 2021 | 796 | 0.110 |
Why?
|
| Logistic Models | 1 | 2016 | 923 | 0.110 |
Why?
|
| Aging | 1 | 2018 | 664 | 0.110 |
Why?
|
| Lipoprotein Lipase | 1 | 2012 | 5 | 0.110 |
Why?
|
| Carbohydrate Metabolism | 1 | 2012 | 21 | 0.110 |
Why?
|
| Biomedical Research | 1 | 2017 | 400 | 0.110 |
Why?
|
| Hematopoiesis | 1 | 2013 | 28 | 0.110 |
Why?
|
| Dietary Fiber | 1 | 2013 | 47 | 0.110 |
Why?
|
| Trace Elements | 1 | 2013 | 30 | 0.110 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2013 | 43 | 0.110 |
Why?
|
| DNA Methylation | 1 | 2016 | 325 | 0.110 |
Why?
|
| Anthropometry | 1 | 2013 | 97 | 0.110 |
Why?
|
| Smoking | 2 | 2017 | 940 | 0.110 |
Why?
|
| Lung | 1 | 2015 | 446 | 0.110 |
Why?
|
| Magnesium | 1 | 2013 | 97 | 0.100 |
Why?
|
| Blood Proteins | 1 | 2012 | 66 | 0.100 |
Why?
|
| Weight Gain | 1 | 2013 | 136 | 0.100 |
Why?
|
| Waist-Hip Ratio | 3 | 2017 | 34 | 0.100 |
Why?
|
| Models, Genetic | 1 | 2012 | 172 | 0.100 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 306 | 0.100 |
Why?
|
| Proteins | 1 | 2014 | 369 | 0.100 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2011 | 36 | 0.100 |
Why?
|
| Cation Transport Proteins | 1 | 2011 | 34 | 0.100 |
Why?
|
| Homeostasis | 1 | 2012 | 188 | 0.100 |
Why?
|
| Coronary Disease | 1 | 2012 | 124 | 0.100 |
Why?
|
| Lipids | 1 | 2012 | 235 | 0.100 |
Why?
|
| Bone Marrow Cells | 1 | 2011 | 81 | 0.090 |
Why?
|
| Feeding Behavior | 1 | 2014 | 454 | 0.090 |
Why?
|
| Zinc | 1 | 2011 | 128 | 0.090 |
Why?
|
| Stem Cells | 1 | 2011 | 141 | 0.090 |
Why?
|
| Educational Status | 2 | 2022 | 313 | 0.090 |
Why?
|
| United States | 5 | 2018 | 4223 | 0.090 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 2721 | 0.080 |
Why?
|
| Case-Control Studies | 3 | 2018 | 1130 | 0.080 |
Why?
|
| Body Weight | 1 | 2010 | 434 | 0.080 |
Why?
|
| Endothelial Cells | 1 | 2011 | 308 | 0.080 |
Why?
|
| MicroRNAs | 1 | 2012 | 426 | 0.070 |
Why?
|
| Genomics | 2 | 2018 | 223 | 0.070 |
Why?
|
| Waist Circumference | 2 | 2017 | 89 | 0.070 |
Why?
|
| Diet | 1 | 2012 | 801 | 0.070 |
Why?
|
| Comorbidity | 2 | 2019 | 623 | 0.070 |
Why?
|
| Sex Factors | 2 | 2019 | 898 | 0.070 |
Why?
|
| Pilot Projects | 2 | 2019 | 661 | 0.070 |
Why?
|
| Genetic Variation | 2 | 2019 | 387 | 0.060 |
Why?
|
| Hospital Mortality | 2 | 2017 | 187 | 0.060 |
Why?
|
| Age Factors | 2 | 2019 | 1033 | 0.060 |
Why?
|
| Prognosis | 2 | 2018 | 739 | 0.060 |
Why?
|
| Amyloid | 1 | 2023 | 54 | 0.050 |
Why?
|
| Linkage Disequilibrium | 2 | 2012 | 85 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 583 | 0.050 |
Why?
|
| Positron-Emission Tomography | 1 | 2023 | 80 | 0.050 |
Why?
|
| Linear Models | 2 | 2013 | 275 | 0.050 |
Why?
|
| Memory | 1 | 2022 | 170 | 0.050 |
Why?
|
| Multifactorial Inheritance | 1 | 2019 | 19 | 0.040 |
Why?
|
| Prevalence | 2 | 2016 | 1455 | 0.040 |
Why?
|
| Physical Fitness | 1 | 2019 | 90 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2016 | 1015 | 0.040 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2018 | 26 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2013 | 1378 | 0.040 |
Why?
|
| Databases, Genetic | 1 | 2018 | 93 | 0.040 |
Why?
|
| Europe | 1 | 2017 | 101 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2022 | 560 | 0.040 |
Why?
|
| Adipose Tissue | 1 | 2018 | 177 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 400 | 0.040 |
Why?
|
| Body Fat Distribution | 1 | 2017 | 24 | 0.040 |
Why?
|
| District of Columbia | 1 | 2017 | 71 | 0.040 |
Why?
|
| Nutrition Surveys | 1 | 2018 | 242 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2021 | 1369 | 0.040 |
Why?
|
| Heterozygote | 1 | 2016 | 93 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2016 | 10 | 0.030 |
Why?
|
| Atrial Flutter | 1 | 2016 | 6 | 0.030 |
Why?
|
| Survival Rate | 1 | 2017 | 311 | 0.030 |
Why?
|
| Exercise Therapy | 1 | 2016 | 69 | 0.030 |
Why?
|
| Residual Volume | 1 | 2015 | 3 | 0.030 |
Why?
|
| Pulmonary Diffusing Capacity | 1 | 2015 | 5 | 0.030 |
Why?
|
| Registries | 1 | 2018 | 335 | 0.030 |
Why?
|
| Total Lung Capacity | 1 | 2015 | 6 | 0.030 |
Why?
|
| Length of Stay | 1 | 2017 | 185 | 0.030 |
Why?
|
| Respiratory Function Tests | 1 | 2015 | 55 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 173 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 114 | 0.030 |
Why?
|
| Brain | 1 | 2023 | 1346 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2014 | 17 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2021 | 2026 | 0.030 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2014 | 28 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2018 | 517 | 0.030 |
Why?
|
| Pharmacogenetics | 1 | 2014 | 49 | 0.030 |
Why?
|
| Young Adult | 2 | 2015 | 4268 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2014 | 195 | 0.030 |
Why?
|
| Adolescent | 2 | 2015 | 5363 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2013 | 30 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2013 | 11 | 0.030 |
Why?
|
| Incidence | 1 | 2016 | 922 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2013 | 15 | 0.030 |
Why?
|
| Massachusetts | 1 | 2013 | 31 | 0.030 |
Why?
|
| Antigens, CD34 | 1 | 2013 | 19 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 190 | 0.030 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2013 | 33 | 0.030 |
Why?
|
| Ribosomes | 1 | 2012 | 32 | 0.030 |
Why?
|
| TRPM Cation Channels | 1 | 2013 | 35 | 0.030 |
Why?
|
| Netherlands | 1 | 2012 | 10 | 0.030 |
Why?
|
| Cholesterol, HDL | 1 | 2012 | 97 | 0.030 |
Why?
|
| Discriminant Analysis | 1 | 2012 | 23 | 0.030 |
Why?
|
| Diet Surveys | 1 | 2012 | 101 | 0.030 |
Why?
|
| Serum Albumin | 1 | 2012 | 50 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2012 | 142 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2013 | 215 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2012 | 88 | 0.030 |
Why?
|
| ROC Curve | 1 | 2012 | 138 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 133 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2012 | 119 | 0.030 |
Why?
|
| Atherosclerosis | 1 | 2013 | 134 | 0.020 |
Why?
|
| Life Style | 1 | 2013 | 308 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2013 | 194 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2013 | 305 | 0.020 |
Why?
|
| Body Size | 1 | 2010 | 32 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 974 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2011 | 268 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2013 | 339 | 0.020 |
Why?
|
| Glucose | 1 | 2011 | 230 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2013 | 539 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2012 | 753 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 643 | 0.020 |
Why?
|
| Mice | 1 | 2012 | 5913 | 0.010 |
Why?
|
| Animals | 1 | 2012 | 15081 | 0.010 |
Why?
|